12-month follow-up of intensive outpatient treatment for PTSD combining prolonged exposure therapy, EMDR and physical activity

Table 2 Changes in symptoms, functioning, and well-being from pre-treatment to 12-month follow-up

	Pre	Post	3 m FU	12 m FU	F	p	η² 12 m	d pre-post	d pre-12 m
PSS-I	32.07 (7.96)	17.92 (10.60)	14.43 (11.09)	14.71 (10.53)	42.92	< 0.001	0.558	1.51	1.86
PCL-5	51.89 (11.48)	34.07 (15.28)	29.60 (16.61)	30.87 (17.16)	29.54	< 0.001	0.465	1.32	1.44
BAI	26.14 (13.30)	16.81 (12.33)	16.74 (13.67)	16.64 (12.97)	20.89	< 0.001	0.381	0.72	0.72
BDI-II	28.38 (11.84)	19.30 (10.83)	18.51 (13.35)	19.38 (11.88)	11.95	< 0.001	0.260	0.80	0.76
WSAS	22.55 (7.96)	19.13 (7.87)	18.47 (9.08)	19.24 (9.30)	3.61	0.016	0.096	0.43	0.38
IIP-64	1.73 (0.47)	1.43 (0.50)	1.37 (0.57)	1.40 (0.41)	9.55	< 0.001	0.219	0.62	0.75
WHO-5	31.20 (20.54)	41.58 (18.20)	44.70 (17.77)	44.55 (17.73)	7.03	< 0.001	0.171	-0.53	-0.70

Note. Pre = pre-treatment, Post = post-treatment, 3 m FU = 3-month follow-up, 12 m FU = 12-month follow-up, PSS-I = PTSD Symptom Scale Interview, PCL-5 = PTSD Checklist for DSM-5, BAI = Beck Anxiety Inventory, BDI-II = Beck Depression Inventory II, WSAS = Work and Social Adjustment Scale, IIP-64 = Inventory of interpersonal problems, WHO-5 = World Health Organization Well-Being Index. N = 35. Cohen’s d calculated using pooled standard deviations

ISSN: 1471-244X